Browsing by Author Edel, Michael John

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 20 of 22  next >
Issue DateTitleAuthor(s)
8-Apr-2019Adapting cord blood collection and banking Standard Operating Procedures for HLA-homozygous induced Pluripotent Stem Cells production and banking for clinical applicationÁlvarez Palomo, Ana Belén; Vives Armengol, Joaquim; Casaroli Marano, Ricardo Pedro; Gómez, Susana G.; Rodriguez Gómez, Luciano; Edel, Michael John; Querol Giner, Sergi
8-Sep-2017Advancing induced pluripotent stem cell (iPSC) technology by assessing genetic instability and immune responseRequena Osete, Jordi
Jul-2017Bioengineered Bruch's-like extracellular matrix promotes retinal pigment epithelial differentiationMcLenachan, Samuel; Hao, Erwei; Zhang, Dan; Zhang, Ling; Edel, Michael John; Chen, Fred K.
8-Feb-2024Blocking IL-6 signaling prevents astrocyte-induced neurodegeneration in an iPSC-based model of Parkinson’s diseasePons Espinal, Meritxell; Blasco Agell, Lucas; Fernández Carasa, Irene; Andrés Benito, Pol; Domenico, Angelique Di; Richaud-Patin, Yvonne; Baruffi, Valentina; Marruecos, Laura; Espinosa, Lluís; Garrido, Alicia; Tolosa, Eduardo; Edel, Michael John; Juan, Manel; Mosquera, José Luis; Ferrer, Isidro (Ferrer Abizanda); Raya, Angel; Consiglio, Antonella
Apr-2012Cyclin A1 is essential for setting the pluripotent state and reducing tumorigenicity of induced pluripotent stem cellsMcLenachan, Samuel; Menchón Najas, Cristina; Raya Chamorro, Ángel; Consiglio, Antonella; Edel, Michael John
5-Apr-2016Effects of the spinal cord injury environment on the differentiation capacity of human neural stem cells derived from induced pluripotent stem cells.López-Serrano, Clara; Torres-Espín, Abel; Hernández, Joaquim; Alvarez Palomo, Ana Belen; Requena Osete, Jordi; Gasull Casanova, Xavier; Edel, Michael John; Navarro, X. (Xavier)
17-Nov-2012Efficient generation of A9 midbrain dopaminergic neurons by lentiviral delivery of LMX1A in human embryonic stem cells and Induced Pluripotent Stem CellsSánchez-Danés, Adriana; Consiglio, Antonella; Richaud-Patin, Yvonne; Rodríguez-Pizà, Ignacio; Dehay, B.; Edel, Michael John; Bove, J.; Memo, Maurizio; Vila, M.; Raya Chamorro, Ángel; Izpisúa Belmonte, Juan Carlos
3-Jan-2019Global proteomic and methylome analysis in human induced pluripotent stem cells reveals overexpression of a human TLR3 affecting proper innate immune response signalingRequena Osete, Jordi; Alvarez Palomo, Ana Belen; Codina Pascual, M.; Delgado-Morales, Raul; Moran, Sebastian; Esteller, Manel; Sal, M.; Boronat Barado, Anna; Consiglio, Antonella; Addeleccia Bogle, O.; Wolwertang, E.; Ovchinnikov, D.; Álvarez, Iñaki; Jaraquemada, Dolores; Mezquita Pla, Jovita; Oliva, R.; Edel, Michael John
13-Mar-2017Helios expression coordinates the development of a subset of striatopallidal medium spiny neuronsMartín Ibáñez, Raquel; Pardo Muñoz, Mònica; Giralt Torroella, Albert; Miguez, Andrés; Guardia, Inés; Marion Poll, Lucile; Herranz, Cristina; Esgleas, Miriam; García-Díaz Barriga, Gerardo; Edel, Michael John; Vicario Abejón, Carlos; Alberch i Vié, Jordi; Girault, Jean-Antoine; Chan, Susan; Kastner, Philippe; Canals i Coll, Josep M.
12-Jan-2012Increased dosage of tumor suppressors limits the tumorigenicity of iPS cells without affecting their pluripotencyMenendez, Sergio; Camus, Suzanne; Herreria, Aida; Paramonov, Ida; Morera, Laura B.; Collado, Manuel; Pekarik, Vlad; Maceda, Iago; Edel, Michael John; Consiglio, Antonella; Sánchez-Danés, Adriana; Li, Han; Serrano, Manuel; Izpisúa Belmonte, Juan Carlos
19-Dec-2014iPS Cells for Modelling and Treatment of Retinal DiseasesChen, Fred K.; McLenachan, Samuel; Edel, Michael John; Da Cruz, Lyndon; Coffey, Peter J.; Mackey, David A.
26-Dec-2013mRNA transfection of mouse and human neural stem cell culturesMcLenachan, Samuel; Zhang, Dan; Palomo, A.B.; Edel, Michael John; Chen, Fred K.
29-Jan-2015Myogenic Precursors from iPS Cells for Skeletal Muscle Cell Replacement Therapy.Roca, Isart; Requena Osete, Jordi; Edel, Michael John; Alvarez Palomo, Ana Belen
7-Jan-2014Plant hormones increase efficiency of reprogramming mouse somatic cells to induced pluripotent stem cells and reduce tumorigenicityÁlvarez Palomo, Ana Belén; McLenachan, Samuel; Requena Osete, Jordi; Menchón Najas, Cristina; Barrot i Feixat, Carme; Chen, Fred K.; Munné Bosch, Sergi; Edel, Michael John
12-Feb-2015Potential Role of Induced Pluripotent Stem Cells (IPSCs) for Cell-Based Therapy of the Ocular SurfaceCasaroli Marano, Ricardo Pedro; Nieto-Nicolau, Nuria; Martínez-Conesa, Eva M.; Edel, Michael John; Álvarez Palomo, Ana Belén
15-May-2015Prospects for clinical use of reprogrammed cells for autologous treatment of macular degenerationAlvarez Palomo, Ana Belen; McLenachan, Samuel; Chen, Fred K.; Da Cruz, Lyndon; Dilley, Rodney J.; Requena Osete, Jordi; Lucas, Michaela; Lucas, Andrew; Drukker, Micha; Edel, Michael John
15-Mar-2010Rem2 GTPase maintains survival of human embryonic stem cells as well as enhancing reprogramming by regulating p53 and cyclin D1Edel, Michael John; Menchón Najas, Cristina; Menendez, Sergio; Consiglio, Antonella; Raya Chamorro, Ángel; Izpisúa Belmonte, Juan Carlos
9-Jun-2011The Role of the Cell Cycle in Human Embryonic Stem Cell Self-Renewal and PluripotencyMenchón Najas, Cristina
28-May-2015The possible future roles for IPSC-Derived therapy for Autoimmune Diseases.Hew, Meilyn; O'Connor, Kevin; Edel, Michael John; Lucas, Michaela
4-Apr-2014The power and the promise of cell reprogramming: Personalized autologous body organ and cell transplantationÁlvarez Palomo, Ana Belén; Lucas, Michaela; Dilley, Rodney J.; McLenachan, Samuel; Chen, Fred K.; Requena Osete, Jordi; Farrera Sal, Martí; Lucas, Andrew; Álvarez, Iñaki; Jaraquemada, Dolores; Edel, Michael John